Interferon

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
18871
Adjuvant phase III trial in malignant melanoma comparing Interferon r alpha-2 to r gamma to a control group after surgical removal of either high risk primary (> 3 mm) or curative resection of lymph node metastasis (stage IIB) (Jointly with the Deutsche Krebsgesellschaft - Protocol DKG 80-1)
16861
PHASE II STUDY OF HUMAN RECOMBINANT Interferon-GAMMA (rIFN-Y) IN ADVANCED RENAL ADENOCARCINOMA .
18852
PILOT PHASE II STUDY ON RECOMBINANT Interferon ALPHA 2 IN ADVANCED MALIGNANT MELANOMA.
06851
Phase II trial of recombinant alpha-2 interferon in patients with myelodysplastic syndromes
06842
Phase II trial of human alpha-2 recombinant interferon for chronic myeloid leukemia in the chronic phase
06887
Randomized phase III study comparing hydroxyurea with Interferon alpha-2C in the chronic phase of chronic myeloid leukemia

Back to Treatment-list